Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis

Annals of Pharmacotherapy

Volumn 41, Issue 1, 2007, Pages 41-45

  Halil, Meltem ^a   Cankurtaran, Mustafa ^a   Yavuz, Burcu Balam ^a   Ulger, Zekeriya ^a   Piskinpasa, Serhan ^a   Gedik, Arzu ^a   Haznedaroglu, Ibrahim Celalettin ^a   Kirazli, Serafettin ^a   Ariogul, Servet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Elderly; Hemostasis; Osteoporosis; Strontium ranelate

Indexed keywords

ASPARTAME; CALCIUM; CARDIOLIPIN ANTIBODY; D DIMER; FIBRINOGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; MALTODEXTRIN; MANNITOL; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; STRONTIUM RANELATE; THROMBIN; THROMBOPLASTIN; VITAMIN D;

ACTIVATED PROTEIN C RESISTANCE; AGED; ARTICLE; BLEEDING TIME; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; STATISTICAL ANALYSIS; THROMBOCYTE FUNCTION; VENOUS THROMBOEMBOLISM;

AGED; BLEEDING TIME; FEMALE; HEMOSTATICS; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; PROSPECTIVE STUDIES; THIOPHENES; TIME FACTORS;

EID: 33846419499     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H506     Document Type: Article

References (19)

1. Ammann P. Strontium ranelate: a novel mode of action leading to renewed bone quality. Osteoporos Int 2005;16(suppl 1):S11-5.
2. Marie PJ. Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 2006;38(2 suppl 1):S10-4. Epub 2006 Jan 24.
3. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001;69:121-9.
4. Ortolani S, Vai S. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages. Bone 2006;38(2 suppl 1):19-22.
5. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459-68.
6. Rizzoli R, Reginster JY, Diaz-Curiel M, et al. Patients at high risk of hip fracture benefit from treatment with strontium ranelate (abstract). Osteoporos Int 2004;15(suppl 1):OC39.
7. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005;90:2816-22. Epub 2005 Feb 22.
8. Delmas PD. Clinical effects of strontium ranelate in women with post-menopausal osteoporosis. Osteoporos Int 2005;16(suppl 1):S16-9.
9. Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 2005;20:1569-78. Epub 2005 Apr 27.
10. SPC: summary product characteristics (EMEA 2005). www.emea.eu.int/ humandocs/PDFs/EPAR/protelos/121604en6.pdf (accessed 2005 Jul 14).
11. Buyukasik Y, Karakus S, Goker H, et al. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagul Fibrinolysis 2002;13:349-53.
12. Reginster JY, Sarlet N, Lecart MP. Fractures in osteoporosis: the challenge for the new millennium. Osteoporos Int 2005;16(suppl 1):S1-3.
13. Population aging-a public health challenge. Fact sheet no. 135. World Health Organization, September 1998.
14. Report on osteoporosis in the European Community. Action for prevention. European Communities, 1998. www.iofbonehealth.org/publications/eu-policy-report- of-1998.html (accessed 2006 Dec 11).
15. Cankurtaran M, Yavuz BB, Halil M, Dagli N, Ariogul S. General characteristics, clinical features and related factors of osteoporosis in a group of elderly Turkish men. Aging Clin Exp Res 2005;17:108-15.
16. Gold DT. Osteoporosis and quality of life psychosocial outcomes and interventions for individual patients. Clin Geriatr Med 2003;19:271-80.
17. Martin AR, Sornay-Rendu E, Chandler JM, Duboeuf F, Girman CJ, Delmas PD. The impact of osteoporosis on quality-of-life: the OFELY cohort. Bone 2002;31:32-6.
18. Compston J. Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis. Osteoporos Int 2005;16(suppl 1):S4-6.
19. Boivin G, Deloffre P, Perrat B, et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S12911) administration. J Bone Miner Res 1996;11:1302-11.